#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Association of Secondhand Smoke Exposure with Pediatric Invasive Bacterial Disease and Bacterial Carriage: A Systematic Review and Meta-analysis


Background:
A number of epidemiologic studies have observed an association between secondhand smoke (SHS) exposure and pediatric invasive bacterial disease (IBD) but the evidence has not been systematically reviewed. We carried out a systematic review and meta-analysis of SHS exposure and two outcomes, IBD and pharyngeal carriage of bacteria, for Neisseria meningitidis (N. meningitidis), Haemophilus influenzae type B (Hib), and Streptococcus pneumoniae (S. pneumoniae).

Methods and Findings:
Two independent reviewers searched Medline, EMBASE, and selected other databases, and screened articles for inclusion and exclusion criteria. We identified 30 case-control studies on SHS and IBD, and 12 cross-sectional studies on SHS and bacterial carriage. Weighted summary odd ratios (ORs) were calculated for each outcome and for studies with specific design and quality characteristics. Tests for heterogeneity and publication bias were performed. Compared with those unexposed to SHS, summary OR for SHS exposure was 2.02 (95% confidence interval [CI] 1.52–2.69) for invasive meningococcal disease, 1.21 (95% CI 0.69–2.14) for invasive pneumococcal disease, and 1.22 (95% CI 0.93–1.62) for invasive Hib disease. For pharyngeal carriage, summary OR was 1.68 (95% CI, 1.19–2.36) for N. meningitidis, 1.66 (95% CI 1.33–2.07) for S. pneumoniae, and 0.96 (95% CI 0.48–1.95) for Hib. The association between SHS exposure and invasive meningococcal and Hib diseases was consistent regardless of outcome definitions, age groups, study designs, and publication year. The effect estimates were larger in studies among children younger than 6 years of age for all three IBDs, and in studies with the more rigorous laboratory-confirmed diagnosis for invasive meningococcal disease (summary OR 3.24; 95% CI 1.72–6.13).

Conclusions:
When considered together with evidence from direct smoking and biological mechanisms, our systematic review and meta-analysis indicates that SHS exposure may be associated with invasive meningococcal disease. The epidemiologic evidence is currently insufficient to show an association between SHS and invasive Hib disease or pneumococcal disease. Because the burden of IBD is highest in developing countries where SHS is increasing, there is a need for high-quality studies to confirm these results, and for interventions to reduce exposure of children to SHS.

: Please see later in the article for the Editors' Summary


Vyšlo v časopise: Association of Secondhand Smoke Exposure with Pediatric Invasive Bacterial Disease and Bacterial Carriage: A Systematic Review and Meta-analysis. PLoS Med 7(12): e32767. doi:10.1371/journal.pmed.1000374
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1000374

Souhrn

Background:
A number of epidemiologic studies have observed an association between secondhand smoke (SHS) exposure and pediatric invasive bacterial disease (IBD) but the evidence has not been systematically reviewed. We carried out a systematic review and meta-analysis of SHS exposure and two outcomes, IBD and pharyngeal carriage of bacteria, for Neisseria meningitidis (N. meningitidis), Haemophilus influenzae type B (Hib), and Streptococcus pneumoniae (S. pneumoniae).

Methods and Findings:
Two independent reviewers searched Medline, EMBASE, and selected other databases, and screened articles for inclusion and exclusion criteria. We identified 30 case-control studies on SHS and IBD, and 12 cross-sectional studies on SHS and bacterial carriage. Weighted summary odd ratios (ORs) were calculated for each outcome and for studies with specific design and quality characteristics. Tests for heterogeneity and publication bias were performed. Compared with those unexposed to SHS, summary OR for SHS exposure was 2.02 (95% confidence interval [CI] 1.52–2.69) for invasive meningococcal disease, 1.21 (95% CI 0.69–2.14) for invasive pneumococcal disease, and 1.22 (95% CI 0.93–1.62) for invasive Hib disease. For pharyngeal carriage, summary OR was 1.68 (95% CI, 1.19–2.36) for N. meningitidis, 1.66 (95% CI 1.33–2.07) for S. pneumoniae, and 0.96 (95% CI 0.48–1.95) for Hib. The association between SHS exposure and invasive meningococcal and Hib diseases was consistent regardless of outcome definitions, age groups, study designs, and publication year. The effect estimates were larger in studies among children younger than 6 years of age for all three IBDs, and in studies with the more rigorous laboratory-confirmed diagnosis for invasive meningococcal disease (summary OR 3.24; 95% CI 1.72–6.13).

Conclusions:
When considered together with evidence from direct smoking and biological mechanisms, our systematic review and meta-analysis indicates that SHS exposure may be associated with invasive meningococcal disease. The epidemiologic evidence is currently insufficient to show an association between SHS and invasive Hib disease or pneumococcal disease. Because the burden of IBD is highest in developing countries where SHS is increasing, there is a need for high-quality studies to confirm these results, and for interventions to reduce exposure of children to SHS.

: Please see later in the article for the Editors' Summary


Zdroje

1. BerkleyJA

LoweBS

MwangiI

WilliamsT

BauniE

2005

Bacteremia among children admitted to a rural hospital in Kenya.

N Engl J Med

352

39

47

2. BrentAJ

AhmedI

NdirituM

LewaP

NgetsaC

2006

Incidence of clinically significant bacteraemia in children who present to hospital in Kenya: community-based observational study.

Lancet

367

482

488

3. HarrisonLH

BroomeCV

HightowerAW

1989

Haemophilus influenzae type b polysaccharide vaccine: an efficacy study. Haemophilus Vaccine Efficacy Study Group.

Pediatrics

84

255

261

4. KaijalainenT

KharitSM

KvetnayaAS

SirkiaK

HervaE

2008

Invasive infections caused by Neisseria meningitidis, Haemophilus influenzae and Streptococcus pneumoniae among children in St Petersburg, Russia.

Clin Microbiol Infect

14

507

510

5. MulhollandEK

AdegbolaRA

2005

Bacterial infections–a major cause of death among children in Africa.

N Engl J Med

352

75

77

6. O'BrienKL

WolfsonLJ

WattJP

HenkleE

Deloria-KnollM

2009

Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates.

Lancet

374

893

902

7. WattJP

WolfsonLJ

O'BrienKL

HenkleE

Deloria-KnollM

2009

Burden of disease caused by Haemophilus influenzae type b in children younger than 5 years: global estimates.

Lancet

374

903

911

8. World Health Organization

2005

Make every mother and child count.

Geneva

World Health Organization

9. HarrisonLH

TrotterCL

RamsayME

2009

Global epidemiology of meningococcal disease.

Vaccine

27

Suppl 2

B51

63

10. California Environmental Protection Agency

2005

Proposed Identification of Environmental Tobacco Smoke as a TAC; Office of Environmental Health Hazard Assessment CEPA, editor.

Sacramento

California Environmental Protection Agency

11. Office of the Surgeon General

2006

The health consequences of involuntary exposure to tobacco smoke: a report of the Surgeon General; Department of Health and Human Services C, editor.

Atlanta (Georgia)

Office of the Surgeon General

12. BogaertD

De GrootR

HermansPW

2004

Streptococcus pneumoniae colonization: the key to pneumococcal disease.

Lancet Infect Dis

4

144

154

13. GrayBM

ConverseGMIII

DillonHCJr

1980

Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life.

J Infect Dis

142

923

933

14. Lloyd-EvansN

O'DempseyTJ

BaldehI

SeckaO

DembaE

1996

Nasopharyngeal carriage of pneumococci in Gambian children and in their families.

Pediatr Infect Dis J

15

866

871

15. van der PollT

OpalSM

2009

Pathogenesis, treatment, and prevention of pneumococcal pneumonia.

Lancet

374

1543

1556

16. van DeurenM

BrandtzaegP

van der MeerJW

2000

Update on meningococcal disease with emphasis on pathogenesis and clinical management.

Clin Microbiol Rev

13

144

166, table of contents

17. VergnanoS

SharlandM

KazembeP

MwansamboC

HeathPT

2005

Neonatal sepsis: an international perspective.

Arch Dis Child Fetal Neonatal Ed

90

F220

F224

18. MoherD

LiberatiA

TetzlaffJ

AltmanDG

2009

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Ann Intern Med

151

264

269, W264

19. HigginsJP

ThompsonSG

DeeksJJ

AltmanDG

2003

Measuring inconsistency in meta-analyses.

BMJ

327

557

560

20. DerSimonianR

LairdN

1986

Meta-analysis in clinical trials.

Control Clin Trials

7

177

188

21. HigginsJP

ThompsonSG

2002

Quantifying heterogeneity in a meta-analysis.

Stat Med

21

1539

1558

22. GalbraithRF

1988

A note on graphical presentation of estimated odds ratios from several clinical trials.

Stat Med

7

889

894

23. DuvalS

TweedieR

2000

Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis.

Biometrics

56

455

463

24. EggerM

Davey SmithG

SchneiderM

MinderC

1997

Bias in meta-analysis detected by a simple, graphical test.

BMJ

315

629

634

25. BakerM

McNicholasA

GarrettN

JonesN

StewartJ

2000

Household crowding a major risk factor for epidemic meningococcal disease in Auckland children.

Pediatr Infect Dis J

19

983

990

26. CoenPG

TullyJ

StuartJM

AshbyD

VinerRM

2006

Is it exposure to cigarette smoke or to smokers which increases the risk of meningococcal disease in teenagers?

Int J Epidemiol

35

330

336

27. FischerM

HedbergK

CardosiP

PlikaytisBD

HoeslyFC

1997

Tobacco smoke as a risk factor for meningococcal disease.

Pediatr Infect Dis J

16

979

983

28. GreinT

O'FlanaganD

2001

Day-care and meningococcal disease in young children.

Epidemiol Infect

127

435

441

29. HanebergB

TonjumT

RodahlK

Gedde-DahlTW

1983

Factors preceding the onset of meningococcal disease, with special emphasis on passive smoking, symptoms of ill health.

NIPH Ann

6

169

173

30. HodgsonA

SmithT

GagneuxS

AdjuikM

PluschkeG

2001

Risk factors for meningococcal meningitis in northern Ghana.

Trans R Soc Trop Med Hyg

95

477

480

31. HonishL

SoskolneCL

SenthilselvanA

HoustonS

2008

Modifiable risk factors for invasive meningococcal disease during an Edmonton, Alberta outbreak, 1999-2002.

Can J Public Health

99

46

51

32. KrizP

BobakM

KrizB

2000

Parental smoking, socioeconomic factors, and risk of invasive meningococcal disease in children: a population based case-control study.

Arch Dis Child

83

117

121

33. McCallBJ

NeillAS

YoungMM

2004

Risk factors for invasive meningococcal disease in southern Queensland, 2000-2001.

Intern Med J

34

464

468

34. MoodleyJR

CoetzeeN

HusseyG

1999

Risk factors for meningococcal disease in Cape Town.

S Afr Med J

89

56

59

35. O'DempseyTJ

McArdleTF

MorrisJ

Lloyd-EvansN

BaldehI

1996

A study of risk factors for pneumococcal disease among children in a rural area of west Africa.

Int J Epidemiol

25

885

893

36. PereiroI

Diez-DomingoJ

SegarraL

BallesterA

AlbertA

2004

Risk factors for invasive disease among children in Spain.

J Infect

48

320

329

37. RobinsonP

TaylorK

NolanT

2001

Risk-factors for meningococcal disease in Victoria, Australia, in 1997.

Epidemiol Infect

127

261

268

38. SørensenHT

LabouriauR

JensenES

MortensenPB

SchønheyderHC

2004

Fetal growth, maternal prenatal smoking, and risk of invasive meningococcal disease: a nationwide case-control study.

Int J Epidemiol

33

816

820

39. Stanwell-SmithRE

StuartJM

HughesAO

RobinsonP

GriffinMB

1994

Smoking, the environment and meningococcal disease: a case control study.

Epidemiol Infect

112

315

328

40. StuartJM

CartwrightKA

DawsonJA

RickardJ

NoahND

1988

Risk factors for meningococcal disease: a case control study in south west England.

Community Med

10

139

146

41. TullyJ

VinerRM

CoenPG

StuartJM

ZambonM

2006

Risk and protective factors for meningococcal disease in adolescents: matched cohort study.

BMJ

445

450

42. HaddadMB

PorucznikCA

JoyceKE

DeAK

PaviaAT

2008

Risk factors for pediatric invasive pneumococcal disease in the Intermountain West, 1996-2002.

Ann Epidemiol

18

139

146

43. TakalaAK

JeroJ

KelaE

RonnbergPR

KoskenniemiE

1995

Risk factors for primary invasive pneumococcal disease among children in Finland.

JAMA

273

859

864

44. ArnoldC

MakintubeS

IstreGR

1993

Day care attendance and other risk factors for invasive Haemophilus influenzae type b disease.

Am J Epidemiol

138

333

340

45. CochiSL

FlemingDW

HightowerAW

LimpakarnjanaratK

FacklamRR

1986

Primary invasive Haemophilus influenzae type b disease: a population-based assessment of risk factors.

J Pediatr

108

887

896

46. TakalaAK

EskolaJ

PalmgrenJ

RonnbergPR

KelaE

1989

Risk factors of invasive Haemophilus influenzae type b disease among children in Finland.

J Pediatr

115

694

701

47. VadheimCM

GreenbergDP

BordenaveN

ZiontzL

ChristensonP

1992

Risk factors for invasive Haemophilus influenzae type b in Los Angeles County children 18-60 months of age.

Am J Epidemiol

136

221

235

48. FogartyJ

MoloneyAC

NewellJB

1995

The epidemiology of Haemophilus influenzae type b disease in the Republic of Ireland.

Epidemiol Infect

114

451

463

49. JafariHS

AdamsWG

RobinsonKA

PlikaytisBD

WengerJD

1999

Efficacy of Haemophilus influenzae type b conjugate vaccines and persistence of disease in disadvantaged populations. The Haemophilus Influenzae Study Group.

Am J Public Health

89

364

368

50. McVernonJ

AndrewsN

SlackM

MoxonR

RamsayM

2008

Host and environmental factors associated with Hib in England, 1998-2002.

Arch Dis Child

93

670

675

51. MuhlemannK

AlexanderER

WeissNS

PepeM

SchopferK

1996

Risk factors for invasive Haemophilus influenzae disease among children 2-16 years of age in the vaccine era, Switzerland 1991-1993. The Swiss H. Influenzae Study Group.

Int J Epidemiol

25

1280

1285

52. SilfverdalSA

BodinL

HugossonS

GarpenholtO

WernerB

1997

Protective effect of breastfeeding on invasive Haemophilus influenzae infection: a case-control study in Swedish preschool children.

Int J Epidemiol

26

443

450

53. WolffMC

MoultonLH

NewcomerW

ReidR

SantoshamM

1999

A case-control study of risk factors for Haemophilus influenzae type B disease in Navajo children.

Am J Trop Med Hyg

60

263

266

54. DaviesAL

O'FlanaganD

SalmonRL

ColemanTJ

1996

Risk factors for Neisseria meningitidis carriage in a school during a community outbreak of meningococcal infection.

Epidemiol Infect

117

259

266

55. KremastinouJ

BlackwellC

TzanakakiG

KallergiC

EltonR

1994

Parental smoking and carriage of Neisseria meningitidis among Greek schoolchildren.

Scand J Infect Dis

26

719

723

56. KremastinouJ

TzanakakiG

VelonakisE

VoyiatziA

NickolaouA

1999

Carriage of Neisseria meningitidis and Neisseria lactamica among ethnic Greek school children from Russian immigrant families in Athens.

FEMS Immunol Med Microbiol

23

13

20

57. MacLennanJ

KafatosG

NealK

AndrewsN

CameronJC

2006

Social behavior and meningococcal carriage in British teenagers.

Emerg Infect Dis

12

950

957

58. StuartJM

CartwrightKA

RobinsonPM

NoahND

1989

Effect of smoking on meningococcal carriage.

Lancet

2

723

725

59. CardozoDM

Nascimento-CarvalhoCM

AndradeAL

Silvany-NetoAM

DaltroCH

2008

Prevalence and risk factors for nasopharyngeal carriage of Streptococcus pneumoniae among adolescents.

J Med Microbiol

57

185

189

60. ColesCL

KanungoR

RahmathullahL

ThulasirajRD

KatzJ

2001

Pneumococcal nasopharyngeal colonization in young South Indian infants.

Pediatr Infect Dis J

20

289

295

61. GreenbergD

Givon-LaviN

BroidesA

BlancovichI

PeledN

2006

The contribution of smoking and exposure to tobacco smoke to Streptococcus pneumoniae and Haemophilus influenzae carriage in children and their mothers.

Clin Infect Dis

42

897

903

62. LaboutJA

DuijtsL

ArendsLR

JaddoeVW

HofmanA

2008

Factors associated with pneumococcal carriage in healthy Dutch infants: the generation R study.

J Pediatr

153

771

776

63. SungRY

LingJM

FungSM

OppenheimerSJ

CrookDW

1995

Carriage of Haemophilus influenzae and Streptococcus pneumoniae in healthy Chinese and Vietnamese children in Hong Kong.

Acta Paediatr

84

1262

1267

64. AyyildizA

AktasAE

YazgiH

2003

Nasopharyngeal carriage rate of Haemophilus influenzae in children aged 7-12 years in Turkey.

Int J Clin Pract

57

686

688

65. Oguzkaya-ArtanM

BaykanZ

ArtanC

2008

Nasal carriage of Staphylococcus aureus in healthy preschool children.

Jpn J Infect Dis

61

70

72

66. NuortiJP

ButlerJC

FarleyMM

HarrisonLH

McGeerA

2000

Cigarette smoking and invasive pneumococcal disease. Active Bacterial Core Surveillance Team.

N Engl J Med

342

681

689

67. DyeJA

AdlerKB

1994

Effects of cigarette smoke on epithelial cells of the respiratory tract.

Thorax

49

825

834

68. WannerA

SalathéM

O'RiordanTG

1996

Mucociliary clearance in the airways.

Am J Respir Crit Care Med

154

1868

1902

69. ArcaviL

BenowitzNL

2004

Cigarette smoking and infection.

Arch Intern Med

164

2206

2216

70. GaschlerGJ

ZavitzCC

BauerCM

SkrticM

LindahlM

2008

Cigarette smoke exposure attenuates cytokine production by mouse alveolar macrophages.

Am J Respir Cell Mol Biol

38

218

226

71. GreenRM

GallyF

KeeneyJG

AlperS

GaoB

2009

Impact of cigarette smoke exposure on innate immunity: a Caenorhabditis elegans model.

PLoS One

4

e6860

doi:10.1371/journal.pone.0006860

72. Martí-LliterasP

RegueiroV

MoreyP

HoodDW

SausC

2009

Nontypeable Haemophilus influenzae clearance by alveolar macrophages is impaired by exposure to cigarette smoke.

Infect Immun

77

4232

4242

73. SorensenHT

LabouriauR

JensenES

MortensenPB

SchonheyderHC

2004

Fetal growth, maternal prenatal smoking, and risk of invasive meningococcal disease: a nationwide case-control study.

Int J Epidemiol

33

816

820

74. YusufHR

RochatRW

BaughmanWS

GargiulloPM

PerkinsBA

1999

Maternal cigarette smoking and invasive meningococcal disease: a cohort study among young children in metropolitan Atlanta, 1989-1996.

Am J Public Health

89

712

717

75. MorenoSG

SuttonAJ

TurnerEH

AbramsKR

CooperNJ

2009

Novel methods to deal with publication biases: secondary analysis of antidepressant trials in the FDA trial registry database and related journal publications.

BMJ

339

b2981

76. Centers for Disease Control and Prevention (CDC)

2005

Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease–United States, 1998-2003.

MMWR Morb Mortal Wkly Rep

54

893

897

77. De WalsP

DeceuninckG

BoulianneN

De SerresG

2004

Effectiveness of a mass immunization campaign using serogroup C meningococcal conjugate vaccine.

JAMA

292

2491

2494

78. LevineOS

O'BrienKL

KnollM

AdegbolaRA

BlackS

2006

Pneumococcal vaccination in developing countries.

Lancet

367

1880

1882

79. LimSS

SteinDB

CharrowA

MurrayCJ

2008

Tracking progress towards universal childhood immunisation and the impact of global initiatives: a systematic analysis of three-dose diphtheria, tetanus, and pertussis immunisation coverage.

Lancet

372

2031

2046

80. MorrisSK

MossWJ

HalseyN

2008

Haemophilus influenzae type b conjugate vaccine use and effectiveness.

Lancet Infect Dis

8

435

443

81. MadhiSA

AdrianP

KuwandaL

CutlandC

AlbrichWC

2007

Long-term effect of pneumococcal conjugate vaccine on nasopharyngeal colonization by Streptococcus pneumoniae–and associated interactions with Staphylococcus aureus and Haemophilus influenzae colonization–in HIV-Infected and HIV-uninfected children.

J Infect Dis

196

1662

1666

82. MadhiSA

AdrianP

KuwandaL

JassatW

JonesS

2007

Long-term immunogenicity and efficacy of a 9-valent conjugate pneumococcal vaccine in human immunodeficient virus infected and non-infected children in the absence of a booster dose of vaccine.

Vaccine

25

2451

2457

83. ObaroSK

AdegbolaRA

BanyaWA

GreenwoodBM

1996

Carriage of pneumococci after pneumococcal vaccination.

Lancet

348

271

272

84. World Health Organization

2009

WHO Report on the Global Tobacco Epidemic: implementing smoke-free environments.

Geneva

World Health Organization

85. JhaP

ChaloupkaFJ

2000

Tobacco control in developing countries.

Oxford

Oxford University Press

86. LightwoodJM

GlantzSA

2009

Declines in acute myocardial infarction after smoke-free laws and individual risk attributable to secondhand smoke.

Circulation

120

1373

1379

87. SargentRP

ShepardRM

GlantzSA

2004

Reduced incidence of admissions for myocardial infarction associated with public smoking ban: before and after study.

BMJ

328

977

980

Štítky
Interné lekárstvo

Článok vyšiel v časopise

PLOS Medicine


2010 Číslo 12
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Aktuální možnosti diagnostiky a léčby litiáz
nový kurz
Autori: MUDr. Tomáš Ürge, PhD.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#